Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene

Gene

Volumn 208, Issue 1, 1998, Pages 17-24

  Minta, J O ^a   Fung, May ^a   Turner, Stephen ^a   Eren, R ^b   Zemach, L ^b   Rits, M ^b   Goldberger, Gabriel ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Complement factor I; Regulation of gene expression; Transcription

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT FACTOR I; TRANSCRIPTION FACTOR;

ARTICLE; CELL STRAIN HEPG2; CONSENSUS SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGENETICS; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CLONING, MOLECULAR; COMPLEMENT FACTOR I; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; TATA BOX; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

FELIS CATUS;

EID: 0032536331     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(97)00632-X     Document Type: Article

References (47)

1. Ahearn J.M., Fearon D.T. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:1989;183-219.
2. Akira S., Kishimoto T. IL6 and NF-IL6 in acute phase response and viral infection. Immunol. Rev. 127:1992;25-50.
3. Angel P., Imagawa M., Chiu R., Stein B., Imbra R.J., Rahmsdorf H.J., Jonat C., Herrlich P., Karin M. Phorbol ester inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 49:1987;729-739.
4. Behr J.-P., Demeneix B., Loeffler J.P., Mutul J. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. USA. 86:1989;6982-6986.
5. Brenner D.A., O'Hara M., Angel P., Chojkier M., Karin M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 337:1989;661-663.
6. Bucher P., Trifonov E.N. Compilation and analysis of eukaryotic POL II promoter sequences. Nucleic Acid Res. 14:1986;10009-10026.
7. Catterall C.F., Lysons A., Sim R.B., Day A.J., Harris T.J.R. Characterization of the primary amino acid sequence of human complement control protein Factor I from an analysis of cDNA clones. Biochem. J. 242:1987;849-856.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162:1987;156-159.
9. Darnell J.E. Jr., Kerr I.M., Stark G.R. Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
10. Faisst S., Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acid Res. 20:1992;3-26.
11. Fearon D.T. Purification of C3b inactivator and demonstration of its two polypeptide chain structures. J. Immunol. 119:1977;1248-1259.
12. Feinberg A.P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Analyt. Biochem. 132:1983;6-13.
13. Goldberger G., Arnaout M.A., Aden D., Kay R., Rits M., Colten H.R. Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (Factor I) in three hepatoma cell lines. J. Biol. Chem. 259:1984;6492-6497.
14. Goldberger G., Bruns G.A.P., Rits M., Edge M.D., Kwiatkowski D.J. Human complement factor I: analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4. J. Biol. Chem. 262:1987;10065-10071.
15. Gorman C.M., Moffat L.F., Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
16. Ghosh D. Status of the transcription factor database (TFD). Nucleic Acid Res. 21:1993;3117-3118.
17. Gulati P., Guc D., Lemercier C., Lappin D., Whaley K. Expression of the components and regulatory proteins of the classical pathway of complement in normal and diseased synovium. Rheumatol. Int. 14:1994;13-19.
18. Hattori M., Abraham L.J., Northermann W., Fey G.H. Acute phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin-6 response element of the rat α2-macroglobulin gene. Proc. Natl. Acad. Sci. USA. 87:1990;2364-2368.
19. Julien N., Dauchel H., Lemercier C., Sim R.B., Fontaine M., Ripoche J. In vitro biosynthesis of complement factor I by human endothelial cells. Eur. J. Immunol. 22:1992;213-217.
20. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation (Review). J. Biol. Chem. 266:1991;19867-19870.
21. Kunnath-Muglia L.M., Chang G.H., Sim R.G., Day A.J., Ezekowitz R.A.B. Characterization of Xenopus laevis complement factor I structure - conservation of modular factor structure except for an unusual insert not present in human I. Molec. Immunol. 30:1993;1249-1256.
22. Leonardo M.J., Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue specific gene control. Cell. 58:1989;227-229.
23. Locker, J. (1993) Transcription controls: cis-elements and trans-factors. In: Hames, B.D., Higgins, S.J. (Eds.), Gene Transcription: A Practical Approach, pp. 321-345. IRL Press at Oxford University Press, Oxford.
24. Matsusaka T., Fujikawa K., Nishio Y., Makaida N., Matsushima K., Kishimoto T., Akira S. Transcriptional factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA. 90:1993;10193-10197.
25. Minta J.O., Wong M.J., Kozak C.A., Kunnath-Muglia L.M., Goldberger G. cDNA cloning, sequencing and chromosomal assignment of the gene fro mouse complement factor I (C3b/C4b Inactivator): Identification of a divergent segment in factor I. Molec. Immunol. 33:1996;101-112.
26. Mitchell P.J., Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 245:1989;371-378.
27. Muller-Eberhard H.J. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:1988;321-347.
28. Nagasawa S., Ichihara C., Stroud R.M. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b′, as an intermediate cleavage product of C4b by C3b inactivator. J. Immunol. 125:1980;578-582.
29. Nakamura S., Abe K. Genetic ploymorphism of human factor I (C3b inactivator). Human Genet. 71:1985;45-48.
30. 1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146:1977;257-270.
31. Rasmussen J.M. Inherited deficiencies of complement proteins with special reference to congenital deficiency of the regulatoryprotein factor I. APMIS Suppl. 20:1991;5-89.
32. Roesler W.J., Vandenbark G.R., Hanson R.W. Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263:1988;9063-9066.
33. Ross G.D., Lambris J.D., Cain J.A., Newman S.L. Generation of three different fragments of bound C3 with purified factor I or serum. 1. Requirements for factor H vs CR1 co-factor activity. J. Immunol. 129:1982;2051-2060.
34. Sambrook, J., Fritsch, E.F, Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
35. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
36. Serfling E., Barthelmas R., Pfeuffer I., Schenk B., Zarius S., Swoboda R., Mecurio F., Karin M. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:1989;465-473.
37. Seya T., Turner J.R., Atkinson J.P. Purification and characterization of a membrane protein (gp 45-70) that is a co-factor for cleavage of C3b and C4b. J. Exp. Med. 163:1986;837-855.
38. Shiang R., Murray J.C., Morton C.C., Buetow K.H., Wasmuth J.J., Olney A.H., Sanger W.G., Goldgerber G. Mapping of the human complement factor I gene to 4q25. Genomics. 4:1989;82-86.
39. Shimizu H., Mitomo K., Watanabe T., Okamoto S., Yamamoto K. Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol. Cell Biol. 10:1990;561-568.
40. Smale S.T., Baltimore D. The 'initiator' as a transcription control element. Cell. 57:1989;103-113.
41. Smale S.T., Schmidt M.C., Berk A.J., Baltimore D. Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc. Natl. Acad. Sci. USA. 87:1990;4509-4513.
42. Stein B., Cogswell P.C., Baldwin A.S. Jr. Functional and physical association between NF-κB and C/EBP family members: a rel domain-bZIP interaction. Mol. Cell Biol. 13:1993;3964-3974.
43. Vyse T.J., Bates G.P., Walport M.J., Morley B.J. The organization of the human complement factor I gene (IF): A member of the serine protease faminy. Genomics. 24:1994;90-98.
44. Vyse T.J., Morley B.J., Bartok I., Theodoridis E.L., Davies K.A., Webster D.B., Walport M.J. The molecular basis of hereditary complement factor I deficiency. J. Clin. Invest. 97:1996;925-933.
45. Wilson D.R., Juan T.S.-C., Wilde M.D., Fey G.H., Darlington G.J. A 58 base pair region of the human C3 gene confers synergistic inductibility by interleukin-1 and interleukin-6. Mol. Cell. Biol. 10:1990;6181-6191.
46. Wong M.J., Goldgerger G., Isenman D.E., Minta J.O. Processing of human factor I in cos-1 cells co-transfected with factor I and paired basic amino acid cleaving enzyme (PACE) cDNA. Molec. Immunol. 32:1995;379-386.
47. Zenzie-Gregory B., O'Shea-Greenfield A., Smale S.T. Similar mechanisms for transcription initiation mediated through a TATA-box or an initiator element. J. Biol. Chem. 267:1992;2823-2830.